Methylation Support

Methylation Support: A Comprehensive Reference

1. Definition and Overview

Methylation is a universal biochemical reaction that covalently adds methyl groups (–CH₃) to a variety of molecular targets. It plays a critical role in two major global regulatory mechanisms — epigenetic modifications and imprinting — principally via tagging histones and DNA with a methyl group. In the natural-health and nutritional context, the phrase methylation support refers to the ensemble of dietary, supplemental, and lifestyle strategies that supply or conserve the methyl-group donors, cofactors, and enzymatic conditions required for the body's methylation reactions to proceed adequately.

One-carbon metabolism is a metabolic network that integrates nutrient status from the environment to yield multiple biological functions. Composed of the folate and methionine cycle, it generates S-adenosylmethionine (SAM), the universal methyl donor for methylation reactions. These pathways include nucleotide metabolism, maintenance of cellular redox status, lipid biosynthesis, and methylation metabolism.

S-adenosyl methionine (SAM) is the universal cofactor for methylation as the methyl group donor. Methionine adenosyltransferase (MAT) catalyzes SAM formation by linking methionine and ATP. Methylation is then carried out by DNA methyltransferase and histone methyltransferase enzymes. After the targets have been methylated, S-adenosyl homocysteine (SAH) is formed, and homocysteine (HCY) is then released.

Homocysteine must be recycled: it is a toxic metabolite that inhibits the methylation process and can also inactivate some proteins via homocysteinylation, which leads to structural modifications.

2. Biochemical Pathways and Body Systems Involved

2.1 The Folate and Methionine Cycles

The pathway is divided into two main arms: the folate metabolism pathway and the methionine metabolism pathway. The folate metabolism pathway involves the transfer of one-carbon units, which are attached to tetrahydrofolate (THF), to various substrates.

Folate metabolism, also known as one-carbon metabolism, provides the one-carbon units required for several intracellular processes, including the synthesis of DNA and RNA precursors necessary for DNA replication and repair, the synthesis of amino acids, and the synthesis of S-adenosylmethionine (SAM), required for methylation reactions.

One-carbon groups incorporated into reduced tetrahydrofolate (THF) are derived from the metabolism of serine and glycine, and in some tissues, histidine. Derivatives of THF containing one-carbon groups in different reduction states are required for two steps in de novo synthesis of purines (10-formylTHF), for synthesis of thymidylate (5,10-methyleneTHF), and for synthesis of methionine from homocysteine (5-methylTHF).

Once the THF coenzyme is formed, it is first converted to 5,10-methyleneTHF by the vitamin B-6–dependent enzyme serine hydroxymethyltransferase and subsequently irreversibly reduced to 5-methylTHF by methylenetetrahydrofolate reductase (MTHFR). This reaction is key to maintaining the flux of methyl groups for the remethylation of homocysteine to methionine via the vitamin B-12–dependent methionine synthase reaction.

Methionine is the substrate for SAM, a cofactor and methyl group donor for numerous methylation reactions including the methylation of DNA, RNA, neurotransmitters and other small molecules, phospholipids, and proteins including histones. A number of SAM-dependent reactions have regulatory roles by affecting both genome stability and gene transcription, localization of protein, and small molecule degradation.

2.2 Transsulfuration and Redox Balance

A portion of homocysteine can be diverted into the transsulfuration pathway through the action of cystathionine β-synthase and cystathionine γ-lyase, both requiring vitamin B6 as a cofactor. This branch converts homocysteine into cystathionine and subsequently cysteine, which serves as a precursor for the antioxidant glutathione (GSH). Through this linkage, one-carbon metabolism not only supports methylation but also maintains redox balance, a critical determinant of cellular survival and genomic stability.

2.3 Biological Functions Dependent on Methylation

The process of imprinting relies on methylation to determine non-equivalent and complementary regulatory characteristics of the male and female genomes. In addition, lipid methylation in brain tissue, together with biogenic amines that also require methylation for their synthesis, are essential for neurodevelopment and regulation of the psychic equilibrium.

Nucleotides are required for DNA replication, DNA repair, gene expression, and protein translation through ribosomal RNA. Therefore, the one-carbon metabolism pathway is essential for cell growth and function in all cells, but is specifically important for rapidly proliferating cells.

DNA methylation is a reversible epigenetic modification that plays a crucial role in transcriptional gene silencing. Both excessive (hypermethylation) and reduced DNA methylation (hypomethylation) can contribute to the disturbance of the proper course of many important processes in the human body.

3. Contributing and Associated Factors

3.1 Genetic Factors: MTHFR Polymorphisms

MTHFR catalyzes the irreversible conversion of 5,10-methylenetetrahydrofolate to its active form, 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Numerous variants of the MTHFR gene have been recognized, among which the C677T variant is the most extensively studied. The C677T polymorphism, which results in the conversion of valine to alanine at codon 222, is associated with reduced activity and an increased thermolability of the enzyme.

The MTHFR C677T polymorphism is a common variant with an allele frequency of about 35% in the general North American population, and occurs frequently among Caucasian and Asian populations, with rates of approximately 12–15% for individuals who are homozygous for the variant and up to 50% for individuals who are heterozygous.

Impaired MTHFR efficiency is associated with increased levels of homocysteine, which can contribute to increased production of reactive oxygen species and the development of oxidative stress. Homocysteine is acknowledged as an independent risk factor for cardiovascular disease, while chronic inflammation serves as the common underlying factor among these issues.

Many studies have been conducted to determine whether there is an association between the C677T polymorphism and an increased risk of cardiovascular disease, hypertension, diabetes, and overweight/obesity. There is substantial evidence supporting this association, although several studies have concluded that the polymorphism cannot be reliably used for prediction. The evidence remains mixed: a systematic review and meta-analysis showed that the presence of C677T polymorphism in the MTHFR gene has no effect on the incidence of metabolic syndrome.

The MTHFR 677C→T variant reduces enzyme activity and may help to divert the available methyl groups from the DNA methylation pathway toward the DNA synthesis pathway.

3.2 Nutrient Deficiencies

Methyl nutrients include folates (vitamin B9), riboflavin (vitamin B2), cobalamin (vitamin B12), pyridoxine (vitamin B6), and choline, as well as methionine and betaine. These substances play the role of both substrates and cofactors in transformations related to one-carbon metabolism.

Impaired methylation due to folate deficiency leads to elevated homocysteine levels, which may contribute to vascular endothelial dysfunction and increased cardiovascular risk. In pregnancy, folate deficiency is associated with a significantly increased risk of neural tube defects, preterm delivery, fetal growth restriction, spontaneous abortion, and placental abruption.

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease (CVD) and a sensitive marker of vitamin B-12 and folate deficiency.

3.3 Aging

Common lifestyle factors known to influence DNA methylation are diet, behavior, stress, physical activity, psychological stress, smoking, and alcohol consumption, and growing evidence suggests that the resulting epigenetic changes may influence a number of age-related disorders. Chronological age has been shown to have a profound effect on DNA methylation levels, and several epigenetic markers have been suggested to produce estimations of biological age (referred to as epigenetic age).

3.4 Oxidative Stress

Oxidative stress has been shown to limit methyl donor availability, thereby impacting DNA methylation, by promoting transsulfuration and glutathione synthesis while inhibiting the methylation cycle. A nutrient-rich diet and regular, moderate, aerobic exercise reduces oxidative stress and risk of disease by increasing antioxidants and activity of antioxidant enzymes, while also altering gene-specific DNA methylation levels.

3.5 Alcohol Consumption

In epigenome-wide association studies, alcohol has been linked to hypomethylation, particularly in a cystine transporter gene that enhances glutathione production for antioxidant defense. Differential methylation in pre-selected oxidative stress-related genes has also been detected.

3.6 Gut Microbiome

Bacteria play a role in the methylation cycle. Many Bifidobacteria are folate producers, while other bacterial genera, like Lactobacilli, are folate consumers. Gut dysbiosis can therefore lead to hypo- or hypermethylation, depending on which genera predominate.

4. Nutrients, Herbs, and Natural Ingredients

4.1 Folate (Vitamin B9)

Definition and forms: Folate is an essential water-soluble vitamin occurring naturally in select foods as well as in the synthetic form (folic acid) used in supplements and in food fortification programs. Folates are essential nutrients entirely derived from dietary sources, mainly from the consumption of green leafy vegetables, fruits, cereals, and meat. They should be distinguished from folic acid, which is the synthetic form of the vitamin added to foods and found in dietary supplements. After intestinal absorption, dietary folates are reduced and methylated in the liver to form 5-methyltetrahydrofolate (5-MTHF), which is released into the blood and taken up by the cells.

Scientific evidence: There are many critical cellular pathways dependent on folate as a 1-carbon source including DNA, RNA, and protein methylation as well as DNA synthesis and maintenance. A large epigenome-wide association study of 5,841 participants from 10 cohorts using Illumina 450k arrays investigated folate's relationship to genome-wide DNA methylation; the study identified novel epigenetic loci associated with folate and vitamin B-12 intake and found a negative association between folate and DNA methylation, though replication of these methylation loci is necessary in future studies.

Research suggests that DNA methylation relies at least in part on folate intake, with vitamin B12 potentially playing a role. While other vitamins and minerals may also be involved, the current evidence related to dietary intake is limited.

Regarding folic acid supplementation forms, individuals with the MTHFR C677T polymorphism may benefit more from supplementation with L-methylfolate (5-MTHF), which bypasses the enzymatic block and enhances homocysteine clearance. However, excess folic acid intake, especially from supplements and fortified foods, can introduce concerns, particularly in older individuals — elevated folate levels may mask vitamin B12 deficiency, potentially worsening anemia and contributing to cognitive decline.

Evidence strength: Strong for folate's role in nucleotide synthesis and neural tube defect prevention; moderate-to-strong for its role in DNA methylation via SAM generation; mixed for genome-wide methylation effects from dietary folate in healthy adults.

4.2 Vitamin B12 (Cobalamin)

Scientific evidence: Disruption of methionine synthase has wide-ranging implications for all methylation-dependent reactions, including epigenetic modification, but also for the intracellular folate pathway, since methionine synthase uses 5-methyltetrahydrofolate as a one-carbon donor.

Vitamin B12 is an active cofactor for methionine synthase and is involved in homocysteine remethylation from the methyltetrahydrofolate donor. Independent of folate, vitamin B12 deficiency has also been associated with the functional state of folate deficiency, hyperhomocysteinemia, and an increased risk of neural tube defects.

DNA methylation, a central component of the epigenetic network, is altered in response to nutritional influences. In the one-carbon cycle, folate acts as a one-carbon carrier and vitamin B12 acts as co-factor for the enzyme methionine synthase. Both folate and vitamin B12 are important regulators of DNA methylation and play an important role in development in early life.

Severe vitamin B-12 and folate deficiencies result in megaloblastic anemia, which, for vitamin B-12 deficiency, is associated with severe neurological abnormalities.

Evidence strength: Strong for B12's biochemical role as methionine synthase cofactor; strong for the association between deficiency and hyperhomocysteinemia; strong for neural tube defect risk; moderate for direct effects on genome-wide methylation patterns in supplemented populations.

4.3 Vitamin B6 (Pyridoxine)

Scientific evidence: A number of dietary nutrients are required to maintain one-carbon flux, including vitamin B-6 (serine hydroxymethyltransferase activity), riboflavin (MTHFR stability), vitamin B-12 (methionine synthase function), and choline (betaine precursor as a hepatic methyl source via betaine:homocysteine methyltransferase).

In homocysteine metabolism, B6 status influences the transsulfuration pathway; however, B6 alone has modest effects on homocysteine compared with folate/B12, while combinations are more effective.

Evidence strength: Strong for its enzymatic role in the transsulfuration and one-carbon pathways; moderate for homocysteine lowering when used in combination with folate and B12; weaker for standalone DNA methylation effects.

4.4 Riboflavin (Vitamin B2)

Scientific evidence: Riboflavin (vitamin B2) is the precursor for FAD, the cofactor for methylenetetrahydrofolate reductase (MTHFR). MTHFR catalyzes the formation of 5-methyltetrahydrofolate, which acts as a methyl donor for homocysteine remethylation.

In a clinical study of 126 healthy individuals across MTHFR genotype groups, folate and riboflavin were shown to interact to lower plasma total homocysteine, possibly by maximizing the catalytic activity of MTHFR. The effect may be unrelated to MTHFR genotype.

In individuals with the MTHFR 677TT genotype and hypertension, riboflavin supplementation lowered blood pressure in randomized trials, suggesting genotype-specific benefits (McNulty et al., Circulation 2013).

Evidence strength: Moderate, from small-to-medium randomized controlled trials; genotype-specific effects (particularly for MTHFR 677TT) show the most consistent signal.

4.5 Choline and Betaine

Scientific evidence: Together with several B-vitamins (i.e., folate, vitamin B12, vitamin B6, and riboflavin), choline is required for the metabolism of nucleic acids and amino acids, and for the generation of the universal methyl group donor, S-adenosylmethionine (SAM).

Homocysteine can be converted back to methionine in a reaction catalyzed by vitamin B12-dependent methionine synthase, which requires 5-methyltetrahydrofolate as a methyl donor. Alternately, betaine (a metabolite of choline) is used as the methyl donor for the methylation of homocysteine to methionine by the enzyme betaine-homocysteine methyltransferase (BHMT).

Dietary intake of choline can modulate methylation because, via betaine-homocysteine methyltransferase (BHMT), this nutrient and its metabolite betaine regulate the concentrations of S-adenosylhomocysteine and S-adenosylmethionine. Some of the epigenetic mechanisms that modify gene expression without modifying the genetic code depend on the methylation of DNA or of histones; and dietary availability of choline and other methyl-group donors influences both of these methylations.

The essential nutrients folate and choline (through betaine) are metabolically entwined to feed their methyl groups into one-carbon metabolism. A choline-deficient diet in rats produces a 31–40% reduction in liver folate content, 50% lower hepatic SAM levels, and a doubling of plasma homocysteine. Similarly, folate deficiency results in decreased total hepatic choline. Thus, sufficient intakes of both folate and choline (or betaine) contribute to safeguarding the methyl balance in the body.

Choline and betaine intakes were associated with both fasting and post-methionine-load total homocysteine concentrations, especially in participants with low folate and vitamin B-12 status. A population study of 1,325 men and 1,407 women found this inverse association diminished after folic acid food fortification was introduced in the United States.

Recent evidence has clearly demonstrated that transmethylation reactions can consume a significant proportion of the flux of methionine. In particular, synthesis of creatine and phosphatidylcholine consume most methyl groups and their dietary provision could spare methionine.

Evidence strength: Moderate-to-strong for choline/betaine as an alternative pathway for homocysteine remethylation; primarily from observational epidemiological studies and mechanistic biochemical studies; direct clinical RCT evidence for methylation outcomes in humans is more limited.

4.6 S-Adenosylmethionine (SAMe)

Traditional and historical use: SAMe is naturally present in the human body, and there is evidence that it is effective as an antidepressant. SAMe has been marketed in some European countries since the mid-1980s for the treatment of depression and for other medical conditions such as osteoarthritis, fibromyalgia, liver disease, and migraine headaches. SAMe has been recognized as a prescription drug in Italy since 1979, in Spain since 1985, and in Germany since 1989.

Scientific evidence: SAMe serves as the primary methyl donor in the body, transferring methyl groups to a wide range of substrates, including nucleic acids, proteins, phospholipids, and monoamine neurotransmitters. By promoting methylation processes, SAMe may exert beneficial effects on various aspects of health, including joint health, liver function, and emotional well-being.

SAMe has been studied primarily for depression, osteoarthritis, and liver diseases. Although there are hints that it might be helpful for these conditions, the evidence is not conclusive. Data on the long-term safety of SAMe and its safety for use during pregnancy are too limited to draw any conclusions.

Regarding depression specifically: overall, the evidence that oral SAMe may be helpful for depression is not conclusive. At least 40 studies in people have evaluated SAMe for depression, and many of them showed evidence of beneficial effects. However, most of these trials lasted only a few weeks, included a small number of participants, and were not of the highest scientific quality. Also, some studies used injected SAMe rather than an oral form.

A 2016 Cochrane review of 8 trials (934 subjects) found a lack of high-quality evidence to support SAMe use in depression treatment and recommended further evaluation in high-quality randomized controlled trials.

Regarding liver disease: SAMe synthesis is depressed in chronic liver disease, and there has been considerable interest in the utility of SAMe to ameliorate disease severity. Despite encouraging pre-clinical data confirming that SAMe depletion can exacerbate liver injury and supporting a hepatoprotective role for SAMe therapy, to date no large, high-quality randomized clinical trials have been performed that establish clinical utility in specific disease states.

Evidence strength: Preliminary-to-moderate across depression, liver disease, and osteoarthritis; evidence consistently described as non-conclusive by NCCIH (NIH) due to small trial sizes, short durations, and methodological limitations.

4.7 Methionine

Scientific evidence: Methionine is required not only for protein synthesis but also as the primary source of methyl groups. However, demethylated methionine can be remethylated by methyl groups from methylneogenesis (via folate) and betaine (synthesized from choline). Methionine is the direct dietary precursor to SAM and is found primarily in animal proteins, eggs, seeds, and nuts.

Evidence strength: Strong for biochemical pathway role; dietary methionine sufficiency is generally achieved in omnivorous diets, and isolated methionine supplementation for methylation purposes has limited clinical trial data.

4.8 Phytochemicals with Epigenetic Activity

Note: The following compounds are not methyl-group donors in the classical sense. Rather, they modulate methylation-enzyme activity. Evidence is primarily preclinical (in vitro and animal), and clinical translation remains an active area of research.

Epigallocatechin-3-gallate (EGCG) — Green Tea (Camellia sinensis)

Traditional use: Green tea has been consumed in China and East Asia for thousands of years, prepared as an infusion of dried leaves. Its use in traditional Chinese medicine is documented as a tonic and restorative beverage; epigenetic properties were not part of the traditional framework.

Scientific evidence: (-)-Epigallocatechin-3-gallate (EGCG), the major polyphenol from green tea, can inhibit DNMT activity and reactivate methylation-silenced genes in cancer cells. With nuclear extracts as the enzyme source, EGCG dose-dependently inhibited DNMT activity, showing competitive inhibition with a K(i) of 6.89 microM. Treatment of human esophageal cancer KYSE 510 cells with 5–50 μM of EGCG for 12–144 hours caused a concentration- and time-dependent reversal of hypermethylation of p16(INK4a), retinoic acid receptor beta (RARbeta), O6-methylguanine methyltransferase (MGMT), and human mutL homologue 1 (hMLH1) genes.

Epigallocatechin gallate (EGCG) from green tea can inhibit DNA methyltransferases (DNMTs), thereby potentially reversing hypermethylation and restoring gene function. These findings are from cell culture and animal models. Although overwhelming in vitro evidence supports EGCG's DNMT-inhibitory activity, clinical translation to humans at physiological doses achieved through dietary intake remains unestablished.

Evidence strength: Primarily in vitro and animal studies; human clinical evidence for EGCG as a DNA methylation modulator is preliminary and insufficient for conclusions about efficacy.

Curcumin (Curcuma longa)

Traditional use: Curcumin is the primary polyphenolic compound of turmeric, which has been used in Ayurvedic medicine in India for millennia as an anti-inflammatory and digestive remedy. Epigenetic modulation was not a recognized concept in traditional Ayurvedic frameworks.

Scientific evidence: Curcumin (turmeric) exhibits neuroprotective effects through its influence on DNA methylation patterns, histone acetylation, and non-coding RNA expression profiles. Curcumin (turmeric), together with genistein (soybean), tea polyphenols (green tea), resveratrol (grapes), and sulforaphane (cruciferous vegetables), has been studied as a bioactive component that alters the DNA methylation and histone modifications required for gene activation or silencing in cancer prevention and therapy. Evidence is predominantly from preclinical studies; clinical data on curcumin's capacity to alter DNA methylation meaningfully in humans at practical doses is very limited, partly due to its poor bioavailability.

Evidence strength: Primarily in vitro and animal; human clinical data for methylation-specific outcomes is weak-to-preliminary.

Resveratrol (grapes, berries, Polygonum cuspidatum)

Traditional use: Resveratrol is a stilbenoid polyphenol found in grape skins, red wine, and Japanese knotweed (Polygonum cuspidatum). Red wine consumption has a long cultural history across Mediterranean and European traditions. P. cuspidatum root is used in traditional Chinese and Japanese medicine as a remedy for inflammation and cardiovascular conditions.

Scientific evidence: Resveratrol (grapes) exhibits neuroprotective effects through its influence on DNA methylation patterns, histone acetylation, and non-coding RNA expression profiles in cellular and animal models. In vitro studies using adipocytes, hepatocytes, and pancreatic β-cells have shown that phytochemicals such as resveratrol, curcumin, and genistein can significantly alter epigenetic markers. Human clinical evidence for resveratrol's direct effect on DNA methylation is sparse.

Evidence strength: Predominantly preclinical; human evidence for methylation-specific effects is preliminary.

Sulforaphane (cruciferous vegetables)

Scientific evidence: A number of phytochemicals found in plant foods alter epigenetic processes by influencing enzyme activities such as 5-cytosine DNA methyltransferase (DNMT). Phytochemicals including polyphenols, soy isoflavones (genistein), parthenolide, curcumin, resveratrol, isothiocyanates, and butyrate (an intestinal product from fiber) affect the activities of methylation enzymes. Sulforaphane, an isothiocyanate from broccoli and other cruciferous vegetables, is included in this list. Evidence is largely from preclinical studies.

Evidence strength: Primarily in vitro; human clinical data for methylation-specific endpoints are limited.

4.9 Zinc

Scientific evidence: Zinc is noted in biochemical references of the methylation cycle as a structural component of certain methylation enzymes. Zinc (Zn) appears in the one-carbon cycle diagram alongside CBS (cystathionine beta synthase), CoQ10, and other cycle components. Zinc is a cofactor for numerous enzymes involved in DNA synthesis and repair pathways that intersect with methylation, though direct clinical evidence for zinc supplementation improving methylation status in human populations is limited and requires further investigation.

Evidence strength: Mechanistic/biochemical; direct human clinical evidence for methylation-specific outcomes is weak.

5. Dietary and Lifestyle Factors

5.1 Dietary Patterns

The concept of "lifestyle" includes different factors such as nutrition, behavior, stress, physical activity, working habits, smoking and alcohol consumption. Increasing evidence shows that environmental and lifestyle factors may influence epigenetic mechanisms, such as DNA methylation, histone acetylation, and microRNA expression. Several lifestyle factors have been identified that might modify epigenetic patterns, such as diet, obesity, physical activity, tobacco smoking, alcohol consumption, environmental pollutants, psychological stress, and working on night shifts.

Multiple dietary and lifestyle factors were found to influence DNA methylation patterns through effects on DNA methyltransferase activity, methyl donor availability, and generation of oxidative stress.

Studies on the effects of single foods, single nutrients, or multivitamin/multimineral supplements were generally scarce and produced conflicting findings. For instance, both in the case of folic acid and polyunsaturated fatty acids, independent studies yield nonconvergent results.

Key dietary food sources of methyl-donor nutrients include:

• Folate: Mainly from green leafy vegetables, fruits, cereals, and meat.
• Vitamin B12: Food sources containing vitamin B12 tend to be animal products, so individuals following vegetarian or vegan diets need to pay particular attention to vitamin B12 intake.
• Choline: Found in eggs, liver, and meat; choline dietary intake varies such that many people do not achieve adequate intakes.

5.2 Alcohol

Alcohol consumption has been found to be strongly associated with blood DNA methylation changes. In epigenome-wide studies, alcohol was linked to hypomethylation at specific loci, including oxidative stress-related genes. Alcohol is also known to interfere with folate absorption and metabolism, thus reducing the availability of methyl donors for the one-carbon cycle.

5.3 Physical Activity

A nutrient-rich diet and regular, moderate, aerobic exercise reduces oxidative stress and risk of disease by increasing antioxidants and activity of antioxidant enzymes, while also altering gene-specific DNA methylation levels. The magnitude and specificity of exercise-induced DNA methylation changes in humans remain an area of active investigation.

5.4 Smoking

Tobacco use has been found to be strongly associated with blood DNA methylation changes in large population-based studies, representing one of the most robust and well-replicated epigenetic signals in the literature.

5.5 Obesity and Metabolic Status

Excess body weight has been found to be strongly associated with blood DNA methylation changes. Altered methylation patterns are observed for genes that control cellular proliferation, programmed cell death, and the formation of new blood vessels. The presence of persistent inflammation in individuals with diabetes mellitus results in the secretion of cytokines that modify the activity and gene expression of enzymes involved in one-carbon metabolism, which is crucial for epigenetic reprogramming.

5.6 Aging and Epigenetic Clocks

Poor diet has been associated with accelerated aging, as evidenced by Horvath's Epigenetic Clock looking at DNA methylation patterns. This emerging field uses site-specific DNA methylation to estimate biological age, distinguishing it from chronological age, and represents a growing area of nutritional epigenomics research.

5.7 Polyphenol-Rich Dietary Patterns

Polyphenol metabolites originating from the gut microbiome might act on epigenetic mechanisms by reducing inflammatory biomarkers and regulating oxidative stress. In fact, polyphenols seem to influence methylation in genes that are critical for cancer. Current evidence for whole-diet polyphenol patterns and methylation is preliminary, derived from a combination of observational studies and mechanistic research.

6. Biomarkers Used in Research and Clinical Assessment

Several measurable markers are used in research to assess one-carbon metabolism and methylation status:

• Plasma homocysteine: Hyperhomocysteinemia is an independent risk factor for cardiovascular disease and a sensitive marker of vitamin B-12 and folate deficiency.
• Red blood cell folate and serum B12: Standard clinical indicators of nutritional adequacy for key methyl-donor nutrients.
• Post-methionine-load (PML) homocysteine: In the absence of recognized markers of choline and betaine status and intake, PML homocysteine can be considered a functional marker of the BHMT pathway. This marker shows the relative contribution of betaine and choline as methyl donors. Available evidence suggests that PML-hyperhomocysteinemia is a functional marker of disturbed one-carbon metabolism.
• Epigenetic clocks: Genome-wide DNA methylation arrays are used in research to estimate biological age acceleration and to study lifestyle and nutritional influences on methylation patterns, though this approach remains a research tool rather than standard clinical practice.

References

• Stover PJ et al. "One Carbon Metabolism and Epigenetics: Understanding the Specificity." PMC, 2016.
• Gueant JL et al. "Methylation: An Ineluctable Biochemical and Physiological Process Essential to the Transmission of Life." PMC, 2020.
• Guéant JL et al. "Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles." PMC, 2022.
• Ducker GS. "Regulatory mechanisms of one-carbon metabolism enzymes." Journal of Biological Chemistry, 2023.
• Crider KS et al. "Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role." PMC, 2012.
• Hannibal L et al. "Vitamin B12, folate, and the methionine remethylation cycle — biochemistry, pathways, and regulation." PubMed, 2019.
• Wasek B et al. "The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases." PMC, 2024.
• Friso S et al. "The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation." PMC, 2009.
• Bahrami A et al. "A Genetic Association Study of MTHFR C677T Polymorphism with Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis." PMC, 2021.
• Linus Pauling Institute. "Choline." Oregon State University Micronutrient Information Center.
• Zeisel SH. "Choline, Other Methyl-Donors and Epigenetics." PubMed, 2017.
• Chiuve SE et al. "Are dietary choline and betaine intakes determinants of total homocysteine concentration?" PubMed, 2010.
• Slow S, Garrow TA. "The nutritional burden of methylation reactions." PubMed, 2013.
• Ueland PM et al. "The Shuttling of Methyl Groups Between Folate and Choline Pathways." MDPI Nutrients, 2025.
• NIH National Center for Complementary and Integrative Health. "S-Adenosyl-L-Methionine (SAMe): In Depth."
• Galizia I et al. "S-adenosyl methionine (SAMe) for depression in adults." Cochrane/PMC, 2016.
• Mato JM et al. "S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility." PubMed, 2012.
• Hariz A, Bhatt DL. "Folic Acid Deficiency." StatPearls, NCBI Bookshelf, 2025.
• Alegría-Torres JA et al. "Epigenetics and lifestyle." PMC, 2011.
• Liu X et al. "DNA Methylation in Cancer: Epigenetic View of Dietary and Lifestyle Factors." PMC, 2023.
• Ros MM et al. "Examining nutrition strategies to influence DNA methylation and epigenetic clocks: a systematic review of clinical trials." PMC/Frontiers in Aging, 2024.
• Shankar S et al. "Epigenetic targets of bioactive dietary components for cancer prevention and therapy." PubMed/Clinical Epigenetics, 2011.
• Fang MZ et al. "Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines." PubMed, 2003.
• Khan MA et al. "Epigenetic effects of green tea polyphenols in cancer." PMC, 2014.
• Huang J et al. "Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation: a large-scale epigenome-wide association analysis in 5841 individuals." PMC, 2019.
• Moat SJ et al. "Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype." PubMed/Clinical Chemistry, 2003.
• McNulty H et al. "Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C→T Polymorphism." Circulation/AHA Journals, 2006.
• Basile F et al. "Homocysteine in the Cardiovascular Setting: What to Know, What to Do, and What Not to Do." PMC, 2025.
• Bekele A et al. "Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy." PMC, 2022.
• Restrepo-Leal AM et al. "Alcohol Consumption and DNA Methylation in a Mediterranean Cohort: A Focus on Oxidative Stress and Aging Biomarkers." PMC, 2026.
• Milagro FI et al. "Link between methyl nutrients and the DNA methylation process in the course of selected diseases in adults." PubMed, 2021.
• Xu L et al. "Choline and betaine consumption lowers cancer risk: a meta-analysis of epidemiologic studies." PMC, 2016.